Evidence map›Paper›PMID 38198823›Full record

ArticleAdvanced healthcare materials2024

Synthetic Particulate Subunit Vaccines for the Prevention of Q Fever.

Gayathri Sam, Karren Plain, Shuxiong Chen, Aminul Islam, Mark E Westman, Ian Marsh, John Stenos, Stephen R Graves, Bernd H A Rehm

Open access · hybridAbstract read
In one paragraph

Article in Advanced healthcare materials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Gayathri SamCentre for Cell Factories and Biopolymers, Griffith Institute for Drug Discovery, Griffith University, Brisbane, QLD, 4111, Australia.
Karren PlainElizabeth Macarthur Agricultural Institute, NSW Department of Primary Industries, Menangle, NSW, 2568, Australia.
Shuxiong ChenCentre for Cell Factories and Biopolymers, Griffith Institute for Drug Discovery, Griffith University, Brisbane, QLD, 4111, Australia.
Aminul IslamAustralian Rickettsial Reference Laboratory, University Hospital, Geelong, VIC, 3220, Australia.
Mark E WestmanElizabeth Macarthur Agricultural Institute, NSW Department of Primary Industries, Menangle, NSW, 2568, Australia.
Ian MarshElizabeth Macarthur Agricultural Institute, NSW Department of Primary Industries, Menangle, NSW, 2568, Australia.
John StenosAustralian Rickettsial Reference Laboratory, University Hospital, Geelong, VIC, 3220, Australia.
Stephen R GravesElizabeth Macarthur Agricultural Institute, NSW Department of Primary Industries, Menangle, NSW, 2568, Australia.
Bernd H A RehmCentre for Cell Factories and Biopolymers, Griffith Institute for Drug Discovery, Griffith University, Brisbane, QLD, 4111, Australia.ORCID 0000-0003-3908-8903
Geelong Hospital · AUGriffith University · AUNew South Wales Department of Primary Industries · AU

Funding

Australian Rickettsial Reference LaboratoryCentre for Cell Factories and BiopolymersGriffith Institute for Drug DiscoveryGriffith University
6 · The paper itself

Abstract

Coxiella burnetti is an intracellular bacterium that causes Q fever, a disease of worldwide importance. Q-VAX

Indexed as

Coxiella burnetiiQ FeverAnimalsBacterial VaccinesGuinea PigsHumansImmunityMiceVaccines, SubunitBacterial VaccinesVaccines, SubunitbiopolymerCoxiella burnetiipolyhydroxybutyrateQ feversubunit vaccine

Identifiers

PMID38198823
PMCPMC11468694
OpenAlexW4390718901

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.